Published in Medicine and Law Weekly, December 16th, 2005
Bologna will advise and support Cylex's top executives and management. He will provide strategic business advice for Cylex products, including ImmuKnow, an immune function assay that, the company says, measures the vitality of a patient's immune system from a drop of blood.
Bologna has significant experience in leading healthcare divisions of Fortune 500 companies as well as public- and venture-backed biotechnology companies. In December 2004, Bologna sold Quorex Pharmaceuticals,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly